Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest of CRYO CELL INTERNATIONAL INC from 31 Aug 2010 to 30 Nov 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.
Summary
CRYO CELL INTERNATIONAL INC quarterly and annual Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest in USD history and change rate from 31 Aug 2010 to 30 Nov 2025.
  • CRYO CELL INTERNATIONAL INC Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest for the quarter ending 30 Nov 2025 was $4,631,970, a 450% decline year-over-year.
  • CRYO CELL INTERNATIONAL INC Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest for the twelve months ending 30 Nov 2025 was $2,337,153, a 183% decline year-over-year.
  • CRYO CELL INTERNATIONAL INC annual Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest for 2025 was $2,337,153, a 183% decline from 2024.
  • CRYO CELL INTERNATIONAL INC annual Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest for 2024 was $2,804,121.
  • CRYO CELL INTERNATIONAL INC annual Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest for 2023 was $13,364,495, a 503% decline from 2022.
Source SEC data
View on sec.gov
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest, Trailing 12 Months (USD)
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest, Quarterly (USD)
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest, YoY Quarterly Change (%)
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest, Annual (USD)
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest, YoY Annual Change (%)

CRYO CELL INTERNATIONAL INC Quarterly Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $2,337,153 $4,631,970 -$3,789,536 -450% 01 Sep 2025 30 Nov 2025 10-K 27 Feb 2026 2025 FY
Q3 2025 $1,452,383 $1,185,996 -$193,869 -14% 01 Jun 2025 31 Aug 2025 10-Q 15 Oct 2025 2025 Q3
Q2 2025 $1,646,252 $575,103 -$897,077 -61% 01 Mar 2025 31 May 2025 10-Q 15 Jul 2025 2025 Q2
Q1 2025 $2,543,329 $533,718 -$260,792 -33% 01 Dec 2024 28 Feb 2025 10-Q 14 Apr 2025 2025 Q1
Q4 2024 $2,804,121 $842,434 +$15,150,624 +95% 01 Sep 2024 30 Nov 2024 10-K 27 Feb 2026 2025 FY
Q3 2024 $12,346,503 $1,379,865 +$312,244 +29% 01 Jun 2024 31 Aug 2024 10-Q 15 Oct 2025 2025 Q3
Q2 2024 $12,658,747 $1,472,180 +$1,125,765 +325% 01 Mar 2024 31 May 2024 10-Q 15 Jul 2025 2025 Q2
Q1 2024 $13,784,512 $794,510 -$420,017 -35% 01 Dec 2023 29 Feb 2024 10-Q 14 Apr 2025 2025 Q1
Q4 2023 $13,364,495 $15,993,058 -$16,615,566 -2669% 01 Sep 2023 30 Nov 2023 10-K 28 Feb 2025 2024 FY
Q3 2023 $3,251,071 $1,067,621 +$426,655 +67% 01 Jun 2023 31 Aug 2023 10-Q 15 Oct 2024 2024 Q3
Q2 2023 $2,824,416 $346,415 -$553,365 -62% 01 Mar 2023 31 May 2023 10-Q 15 Jul 2024 2024 Q2
Q1 2023 $3,377,781 $1,214,527 +$58,833 +5.1% 01 Dec 2022 28 Feb 2023 10-Q 15 Apr 2024 2024 Q1
Q4 2022 $3,318,948 $622,508 +$1,866,188 01 Sep 2022 30 Nov 2022 10-K 28 Feb 2024 2023 FY
Q3 2022 $1,452,760 $640,966 -$620,263 -49% 01 Jun 2022 31 Aug 2022 10-Q 12 Oct 2023 2023 Q3
Q2 2022 $2,073,023 $899,780 -$741,411 -45% 01 Mar 2022 31 May 2022 10-Q 14 Jul 2023 2023 Q2
Q1 2022 $2,814,434 $1,155,694 +$203,203 +21% 01 Dec 2021 28 Feb 2022 10-Q 21 Apr 2023 2023 Q1
Q4 2021 $2,611,231 $1,243,680 01 Sep 2021 30 Nov 2021 10-K 28 Feb 2023 2022 FY
Q3 2021 $1,261,229 01 Jun 2021 31 Aug 2021 10-Q 18 Oct 2022 2022 Q3
Q2 2021 $1,641,191 01 Mar 2021 31 May 2021 10-Q 11 Jul 2022 2022 Q2
Q1 2021 $952,491 01 Dec 2020 28 Feb 2021 10-Q 13 Apr 2022 2022 Q1
Q4 2016 $2,480,212 $347,056 +$842,710 01 Sep 2016 30 Nov 2016 10-K 28 Feb 2017 2016 FY
Q3 2016 $3,322,922 $3,543,199 -$4,441,348 -494% 01 Jun 2016 31 Aug 2016 10-Q 17 Oct 2016 2016 Q3
Q2 2016 $1,118,426 $838,867 +$603,423 +256% 01 Mar 2016 31 May 2016 10-Q 11 Jul 2016 2016 Q2
Q1 2016 $515,003 $122,936 -$434,518 -139% 01 Dec 2015 29 Feb 2016 10-Q 14 Apr 2016 2016 Q1
Q4 2015 $949,521 $495,654 -$225,232 -83% 01 Sep 2015 30 Nov 2015 10-K 28 Feb 2017 2016 FY
Q3 2015 $1,174,753 $898,149 +$636,165 +243% 01 Jun 2015 31 Aug 2015 10-Q 17 Oct 2016 2016 Q3
Q2 2015 $538,588 $235,444 -$5,740 -2.4% 01 Mar 2015 31 May 2015 10-Q 11 Jul 2016 2016 Q2
Q1 2015 $544,328 $311,582 -$132,821 -30% 01 Dec 2014 28 Feb 2015 10-Q 14 Apr 2016 2016 Q1
Q4 2014 $677,149 $270,422 -$145,186 -116% 01 Sep 2014 30 Nov 2014 10-K 29 Feb 2016 2015 FY
Q3 2014 $822,335 $261,984 +$25,198 +11% 01 Jun 2014 31 Aug 2014 10-Q 15 Oct 2015 2015 Q3
Q2 2014 $797,137 $241,184 +$442,048 01 Mar 2014 31 May 2014 10-Q 15 Jul 2015 2015 Q2
Q1 2014 $355,089 $444,403 +$158,073 +55% 01 Dec 2013 28 Feb 2014 10-Q 14 Apr 2014 2014 Q1
Q4 2013 $197,016 $125,236 +$686,717 +85% 01 Sep 2013 30 Nov 2013 10-K 02 Mar 2015 2014 FY
Q3 2013 $489,701 $236,786 +$739,025 01 Jun 2013 31 Aug 2013 10-Q 15 Oct 2014 2014 Q3
Q2 2013 $1,228,726 $200,864 +$1,280,263 +86% 01 Mar 2013 31 May 2013 10-Q 03 Jul 2014 2014 Q2
Q1 2013 $2,508,989 $286,330 +$1,911,248 01 Dec 2012 28 Feb 2013 10-Q 14 Apr 2014 2014 Q1
Q4 2012 $4,420,237 $811,953 -$751,100 -1234% 01 Sep 2012 30 Nov 2012 10-K 28 Feb 2014 2013 FY
Q3 2012 $3,669,137 $502,239 +$1,841,226 +79% 01 Jun 2012 31 Aug 2012 10-Q 15 Oct 2013 2013 Q3
Q2 2012 $5,510,363 $1,481,127 -$1,689,575 -811% 01 Mar 2012 31 May 2012 10-Q 15 Jul 2013 2013 Q2
Q1 2012 $3,820,788 $1,624,918 -$1,897,198 -697% 01 Dec 2011 29 Feb 2012 10-Q 15 Apr 2013 2013 Q1
Q4 2011 $1,923,590 $60,853 01 Sep 2011 30 Nov 2011 10-K 28 Feb 2013 2012 FY
Q3 2011 $2,343,465 -$2,957,506 -482% 01 Jun 2011 31 Aug 2011 10-Q 15 Oct 2012 2012 Q3
Q2 2011 $208,448 01 Mar 2011 31 May 2011 10-Q 16 Jul 2012 2012 Q2
Q1 2011 $272,280 01 Dec 2010 28 Feb 2011 10-Q 16 Apr 2012 2012 Q1
Q3 2010 $614,041 01 Jun 2010 31 Aug 2010 10-Q/A 07 Nov 2011 2011 Q3

CRYO CELL INTERNATIONAL INC Annual Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $2,337,153 -$5,141,274 -183% 01 Dec 2024 30 Nov 2025 10-K 27 Feb 2026 2025 FY
2024 $2,804,121 +$16,168,616 01 Dec 2023 30 Nov 2024 10-K 27 Feb 2026 2025 FY
2023 $13,364,495 -$16,683,443 -503% 01 Dec 2022 30 Nov 2023 10-K 28 Feb 2025 2024 FY
2022 $3,318,948 +$707,717 +27% 01 Dec 2021 30 Nov 2022 10-K 28 Feb 2024 2023 FY
2021 $2,611,231 -$2,428,092 -48% 01 Dec 2020 30 Nov 2021 10-K 28 Feb 2023 2022 FY
2020 $5,039,323 01 Dec 2019 30 Nov 2020 10-K 22 Feb 2022 2021 FY
2016 $2,480,212 -$3,429,733 -361% 01 Dec 2015 30 Nov 2016 10-K 28 Feb 2017 2016 FY
2015 $949,521 +$272,372 +40% 01 Dec 2014 30 Nov 2015 10-K 28 Feb 2017 2016 FY
2014 $677,149 +$480,133 +244% 01 Dec 2013 30 Nov 2014 10-K 29 Feb 2016 2015 FY
2013 $197,016 +$4,617,253 01 Dec 2012 30 Nov 2013 10-K 02 Mar 2015 2014 FY
2012 $4,420,237 -$2,496,647 -130% 01 Dec 2011 30 Nov 2012 10-K 28 Feb 2014 2013 FY
2011 $1,923,590 -$3,827,343 -201% 01 Dec 2010 30 Nov 2011 10-K 28 Feb 2013 2012 FY
2010 $1,903,753 01 Dec 2009 30 Nov 2010 10-K 28 Feb 2012 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.